Clinical Operations

Hybrid clinical trials are not remote everything: an operating playbook

A practical playbook for deciding which clinical trial activities can be site-based, local, in-home, telehealth, or digital while preserving oversight and documentation.

Hybrid trials work best when teams map each activity to the right setting, owner, documentation path, and risk controls instead of trying to make every trial fully remote.

In this guide

Key points

  • The useful question is which activities can safely happen closer to the participant, not whether the whole trial can be remote.
  • Every remote, local, or in-home activity needs a responsible party, data path, escalation plan, and documentation standard.
  • Patient convenience should be balanced with protocol requirements, data quality, safety monitoring, and investigator oversight.

Start with activity mapping

A hybrid clinical trial is not a traditional trial with video calls added on top. It is an operating model where each activity is assigned to the most appropriate setting: research site, local healthcare facility, participant home, telehealth visit, or digital data collection.

FDA guidance on decentralized elements describes trial activities that may occur outside traditional sites, including telehealth visits, local healthcare providers, local laboratories, home visits, and direct distribution of investigational products where appropriate.

Separate activities into four groups

First, identify what must stay site-based because it requires specialized equipment, immediate monitoring, complex administration, or direct investigator oversight. Second, identify what can move local, such as certain labs or imaging when qualified facilities and documentation are in place.

Third, identify what can move home or telehealth, such as follow-up conversations, reminders, some patient-reported outcomes, and low-risk check-ins. Fourth, flag activities that need case-by-case review, especially digital health technologies, participant-performed measures, or workflows where training and variability matter.

Use a case-study scenario

A cardiology follow-up study might keep baseline and high-risk assessments at the research site, allow routine labs at qualified local facilities, conduct symptom check-ins by telehealth, and use remote data collection only after the device workflow and participant training are validated.

That design is more realistic than declaring the study remote. It protects the parts of the protocol that need direct oversight while reducing avoidable burden where the activity can safely move closer to the participant.

The risk is unclear ownership

Decentralized elements fail when nobody can reconstruct who performed the activity, where it happened, what data was created, how it moved, and who reviewed it. The protocol and related study documents should define visit type, visit location, data originator, service providers, safety monitoring, and escalation paths.

For recruiting teams, TrialsNest can support the front-end clarity around visit expectations, patient communication, coordinator follow-up, and status tracking. Final protocol design, medical oversight, and eligibility decisions remain with the authorized sponsor, investigator, and study team.

Sources used for this playbook

FDA guidance on conducting clinical trials with decentralized elements: https://www.fda.gov/media/167696/download

FDA digital health technologies for drug development overview: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development

Sources and editorial notes

Published .

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading